A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer

Clinical trial NCT01036113 · TERMINATED

Trial details

NCT number: NCT01036113
Sponsor: Enzon Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2009-11-01
Primary completion: 2012-02-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.